A Phase III, Multicenter, Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-0431A (A Fixed-Dose Combination Tablet of Sitagliptin and Metformin) in Pediatric Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin)

drug protocol number
MK0431-170
drug sponsor
MSD
drug study
MK-0431A (Sitagliptin / Metformin)
drug trial site
NGHA-R
drug status
Completed
drug phase